Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study "Bo-CRISP"

Completed

Phase N/A Results N/A

Trial Description

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Conditions

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

Patients with an acute ischemic stroke admitted to our stroke unit and treated with clopidogrel

Outcomes

Type Measure Time Frame Safety Issue
Primary Result of platelet function test one day No

Sponsors